Personalized Attention-Deficit/Hyperactivity Disorder (ADHD) Medication Experiment Study - Trial NCT06305078
Access comprehensive clinical trial information for NCT06305078 through Pure Global AI's free database. This phase not specified trial is sponsored by Children's Hospital Medical Center, Cincinnati and is currently Recruiting. The study focuses on Attention Deficit Hyperactivity Disorder. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Children's Hospital Medical Center, Cincinnati
Timeline & Enrollment
N/A
Nov 10, 2023
Dec 31, 2024
Primary Outcome
Decision-Making Involvement Scale,Decisional Conflict Scale (DCS),Behavioral Intention Questions,System Usability Scale,Implementation of Decision
Summary
The primary goal of the project is to test personalized medication experiments to inform
 decisions about future medication use. Our central hypothesis is that our intervention will
 lead to within subject increases in adolescent involvement in decision making and decreases
 in uncertainty about future medication use. The investigators view this open label trial as a
 pilot study to test the feasibility, acceptability, and preliminary efficacy of the
 medication experiment intervention and therefore warrants further testing in a future larger
 trial.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06305078
Non-Device Trial